Literature DB >> 32310161

Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.

Clara Domínguez-Vivero1, Liwen Wu2, Seonjoo Lee2, Masood Manoochehri1, Sarah Cines1,3, Adam M Brickman1, Batool Rizvi1, Anthony Chesebro1, Yunglin Gazes1, Emer Fallon4, Timothy Lynch4, Judith L Heidebrink5, Henry Paulson5, Jill S Goldman1, Edward Huey1,6, Stephanie Cosentino1.   

Abstract

BACKGROUND: Frontotemporal dementia (FTD) is the second most common cause of early-onset neurodegenerative dementia. Several studies have focused on early imaging changes in FTD patients, but once subjects meet full criteria for FTD diagnosis, structural changes are generally widespread.
OBJECTIVE: This study aims to determine the earliest structural brain changes in asymptomatic MAPT MUTATION carriers.
METHODS: This is a cross-sectional multicenter study comparing global and regional brain volume and white matter integrity in a group of MAPT mutation preclinical carriers and controls. Participants belong to multiple generations of six families with five MAPT mutations. All participants underwent a medical examination, neuropsychological tests, genetic analysis, and a magnetic resonance scan (3T, scout, T1-weighted image followed by EPI (BOLD), MPRAGE, DTI, FLAIR, and ASL sequences).
RESULTS: Volumes of five cortical and subcortical areas were strongly correlated with mutation status: temporal lobe (left amygdala, left temporal pole), cingulate cortex (left rostral anterior cingulate gyrus, right posterior cingulate), and the lingual gyrus in the occipital lobe. We did not find significant differences in whole brain volume, white matter hyperintensities volume, and white matter integrity using DTI analysis.
CONCLUSION: Temporal lobe, cingulate cortex and the lingual gyrus seem to be early targets of the disease and may serve as biomarkers for FTD prior to overt symptom onset.

Entities:  

Keywords:  Atrophy; MAPT mutation; brain atrophy; early detection; frontotemporal lobar zzm321990degeneration

Year:  2020        PMID: 32310161     DOI: 10.3233/JAD-190820

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  7 in total

Review 1.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

Review 2.  Pre-symptomatic radiological changes in frontotemporal dementia: propagation characteristics, predictive value and implications for clinical trials.

Authors:  Mary Clare McKenna; Jasmin Lope; Ee Ling Tan; Peter Bede
Journal:  Brain Imaging Behav       Date:  2022-08-03       Impact factor: 3.224

3.  Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration.

Authors:  Harro Seelaar; David J Irwin; Lucia A A Giannini; Daniel T Ohm; Annemieke J M Rozemuller; Laynie Dratch; EunRan Suh; Vivianna M van Deerlin; John Q Trojanowski; Edward B Lee; John C van Swieten; Murray Grossman
Journal:  Acta Neuropathol       Date:  2022-09-06       Impact factor: 15.887

4.  Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia.

Authors:  Megan S Barker; Masood Manoochehri; Sandra J Rizer; Brian S Appleby; Danielle Brushaber; Sheena I Dev; Katrina L Devick; Bradford C Dickerson; Julie A Fields; Tatiana M Foroud; Leah K Forsberg; Douglas R Galasko; Nupur Ghoshal; Neill R Graff-Radford; Murray Grossman; Hilary W Heuer; Ging-Yuek Hsiung; John Kornak; Irene Litvan; Ian R Mackenzie; Mario F Mendez; Belen Pascual; Katherine P Rankin; Katya Rascovsky; Adam M Staffaroni; Maria Carmela Tartaglia; Sandra Weintraub; Bonnie Wong; Bradley F Boeve; Adam L Boxer; Howard J Rosen; Jill Goldman; Edward D Huey; Stephanie Cosentino
Journal:  Cortex       Date:  2021-03-19       Impact factor: 4.644

5.  Proposed research criteria for prodromal behavioural variant frontotemporal dementia.

Authors:  Megan S Barker; Reena T Gottesman; Masood Manoochehri; Silvia Chapman; Brian S Appleby; Danielle Brushaber; Katrina L Devick; Bradford C Dickerson; Kimiko Domoto-Reilly; Julie A Fields; Leah K Forsberg; Douglas R Galasko; Nupur Ghoshal; Jill Goldman; Neill R Graff-Radford; Murray Grossman; Hilary W Heuer; Ging-Yuek Hsiung; David S Knopman; John Kornak; Irene Litvan; Ian R Mackenzie; Joseph C Masdeu; Mario F Mendez; Belen Pascual; Adam M Staffaroni; Maria Carmela Tartaglia; Bradley F Boeve; Adam L Boxer; Howard J Rosen; Katherine P Rankin; Stephanie Cosentino; Katya Rascovsky; Edward D Huey
Journal:  Brain       Date:  2022-04-29       Impact factor: 15.255

6.  Pulsed Arterial Spin Labeling and Segmented Brain Volumetry in the Diagnostic Evaluation of Frontotemporal Dementia, Alzheimer's Disease and Mild Cognitive Impairment.

Authors:  Dominique Cornelius Marterstock; Michael Franz Xaver Knott; Philip Hoelter; Stefan Lang; Timo Oberstein; Johannes Kornhuber; Arnd Doerfler; Manuel A Schmidt
Journal:  Tomography       Date:  2022-01-17

7.  Brain volumetric deficits in MAPT mutation carriers: a multisite study.

Authors:  Stephanie A Chu; Taru M Flagan; Adam M Staffaroni; Lize C Jiskoot; Jersey Deng; Salvatore Spina; Liwen Zhang; Virginia E Sturm; Jennifer S Yokoyama; William W Seeley; Janne M Papma; Dan H Geschwind; Howard J Rosen; Bradley F Boeve; Adam L Boxer; Hilary W Heuer; Leah K Forsberg; Danielle E Brushaber; Murray Grossman; Giovanni Coppola; Bradford C Dickerson; Yvette M Bordelon; Kelley Faber; Howard H Feldman; Julie A Fields; Jamie C Fong; Tatiana Foroud; Ralitza H Gavrilova; Nupur Ghoshal; Neill R Graff-Radford; Ging-Yuek Robin Hsiung; Edward D Huey; David J Irwin; Kejal Kantarci; Daniel I Kaufer; Anna M Karydas; David S Knopman; John Kornak; Joel H Kramer; Walter A Kukull; Maria I Lapid; Irene Litvan; Ian R A Mackenzie; Mario F Mendez; Bruce L Miller; Chiadi U Onyike; Alexander Y Pantelyat; Rosa Rademakers; Eliana Marisa Ramos; Erik D Roberson; Maria Carmela Tartaglia; Nadine A Tatton; Arthur W Toga; Ashley Vetor; Sandra Weintraub; Bonnie Wong; Zbigniew K Wszolek; John C Van Swieten; Suzee E Lee
Journal:  Ann Clin Transl Neurol       Date:  2020-11-28       Impact factor: 5.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.